Atrial fibrillation in mainland China: Epidemiology and current management

Heart

Volumn 95, Issue 13, 2009, Pages 1052-1055

  Zhang, S ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; LOSARTAN; PERINDOPRIL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BRAIN HEMORRHAGE; CATHETER ABLATION; CHINA; CHINESE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART SURGERY; HUMAN; LOW DRUG DOSE; MEDICAL RESEARCH; MEDICAL SOCIETY; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; THROMBOEMBOLISM;

ATRIAL FIBRILLATION; BIOMEDICAL RESEARCH; CATHETER ABLATION; CHINA; HUMANS; STROKE;

EID: 67649577125     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.146589     Document Type: Short Survey

References (35)

1. Cheng TO. The current state of cardiology in China. Int J Cardiol 2004;96:425-439 (Pubitemid 39099506)
2. Cheng TO, Guo J. Catheter ablation for atrial fibrillation: The Chinese experience. Int J Cardiol 2006;111:154. (Pubitemid 44107524)
3. Cheng TO. Atrial fibrillation: the Chinese experience. Int J Cardiol 2007;114:130-131 (Pubitemid 44791459)
4. Zhang S. Epidemiology of atrial fibrillation in China. The 5th China Atrial Fibrillation Symposium, Beijing, 2007.
5. Zhou ZQ, Hu DY, Chen J, et al. An epidemiological survey of atrial fibrillation in China. Chin J Intern Med 2004;43:491-494
6. Wen-Hang QI. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China. Int J Cardiol 2005;105:283-287 (Pubitemid 41605077)
7. Yin Y, Dalal D, Liu Z, et al. Prospective randomized study comparing amiodarone vs amiodarone plus losartan vs amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation. Eur Heart J 2006;27:1841-1846 (Pubitemid 44297391)
8. Hu DY, Sun YH, Zhou ZQ, et al. Risk factors for stroke in Chinese with non valvular atrial fibrillation: a case-control study. Chin J Intern Med 2003;42:157-161
9. Sun YH, Hu DY. The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese. Chin J Intern Med 2004;43:258-260
10. Hu DY, Zhang HP, Sun YH, et al. The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin. Chin J Cardiovasc Dis 2006;34:295-298
11. Hu DY. The efficacy and safety of antithrombotic therapy with warfarin in nonrheumatic atrial fibrillation. Chin J Intern Med 2006;45:800-803
12. Shen AY, Yao JF, Brar SS, et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 2007;50:309-315 (Pubitemid 47061504)
13. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke J Cerebr Circ 2000;31:817-821
14. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. Intern Med (Tokyo, Japan) 2001;40:1183-1188 (Pubitemid 34110494)
15. Zhang S. Chinese Nonvalvular Atrial Fibrillation Anticoagulation Study (CNAFA). The 5th China Atrial Fibrillation Symposium, Beijing, 2007.
16. Hu DY, Chen X, Ma CS. National survey on radiofrequency catheter ablation in China. Chin J Card Arrhythm 2002;6:124-127
17. Chen YH, Chen H, Wu Y, et al. Cardiac electrophysiology in China. Heart Rhythm 2007;4:862. (Pubitemid 46840343)
18. Ma CS, Liu XP, Dong JZ, et al. Radiofrequency catheter ablation of atrial fibrillation originating from the pulmonary veins: two cases report. Chin J Card Pacing Electrophysiol 1999;13:134-136
19. Huang CX, Zhang S, Ma CS, et al. The registration study of catheter ablation in patients with atrial fibrillation in China. Chin J Card Arrhythm 2006;10:468-474
20. Huang CX. The Registration Study of Catheter Ablation in Patients with Atrial Fibrillation in China. The 5th China Atrial Fibrillation Symposium, Beijing, 2007.
21. Liu X, Dong J, Mavrakis HE, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: a randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol 2006;17:1263-1270 (Pubitemid 44808541)
22. Yao Y, Zheng LH, Zhang S, et al. Stepwise linear approach to catheter ablation of atrial fibrillation. Heart Rhythm 2007;in press, accepted manuscript. (Pubitemid 350199250)
23. Li L, Wang ZW, Zhang BR, et al. Electrophysiological evaluation of maze procedure in chronic atrial fibrillation. Chin J Cardiovasc Dis 1996;24:24-27 (Pubitemid 26193933)
24. Cui YQ, Meng X, Wang JG, et al. Follow-up results and risk analysis of modified Mini- Maze procedure using both epicardial and endcardial radiofrequency approach. Chin J Card Arrhythm 2006;10:438-442
25. Yuan B, Zhao S, Zhao Z, et al. Clinical effect of off-pump epicardial microwave ablation of atrial fibrillation. Chin J Cardiovasc Dis 2006;34:316-318
26. Wang CS, Wang SH, Cheng H, et al. Efficacy of radiofrequency maze III procedure for atrial fibrillation combined with mitral valve surgery: a controlled study. Zhonghua Xiong Xin Xue Guan Wai Ke Za Zhi 2007;23:22-24
27. Chen YH, Xu SJ, Bendahhou S, et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254 (Pubitemid 36125211)
28. Yang Y, Xia M, Jin Q, et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905. (Pubitemid 39390498)
29. Xia M, Jin Q, Bendahhou S, et al. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Comm 2005;332:1012-1019 (Pubitemid 40798187)
30. Zhang DF, Liang B, Lin J, et al. KCNE3 R53H substitution in familial atrial fibrillation. Chin Med J 2005;118:1735-1738 (Pubitemid 41631684)
31. Zeng Z, Tan C, Teng S, et al. The single nucleotide polymorphisms of I(Ks) potassium channel genes and their association with atrial fibrillation in a Chinese population. Cardiology 2007;108:97-103. (Pubitemid 47295568)
32. Ma KJ, Li N, Teng SY, et al. Modulation of KCNQ1 current by atrial fibrillation-associated KCNE4 (145E/D) gene polymorphism. Chin Med J 2007;120:150-154 (Pubitemid 46584915)
33. Liu T, Li G, Li L, et al. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 2007;49:1642-1648 (Pubitemid 46551628)
34. Huang CX, Ma CS, Yang YZ, et al. Current knowledge and management recommendations of atrial fibrillation (II). Chin J Card Arrhythm 2006;10:167-197
35. Yang YZ, Ma CS, Zhang S, et al. Current knowledge and recommendations of pulmonary vein and/or superior vena cava isolation by radiofrequency catheter ablation in patient with atrial fibrillation. Chin J Card Arrhythm 2004;8:5-9.